Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.
Ontology highlight
ABSTRACT: Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.
SUBMITTER: Jawad MD
PROVIDER: S-EPMC4771850 | biostudies-other | 2016 Mar
REPOSITORIES: biostudies-other
ACCESS DATA